Monogenic disease therapy developer Lexeo Therapeutics has publicly launched with financing from backers including Lundbeckfonden Ventures.
Author: Callum Cyrus
One Main swerves into $95m Curve round
The CreditEase and Mouro Capital-backed payment technology provider lured personal finance firm OneMain Financial to co-lead its series C round.
Jobandtalent expands series C to $203m
Temporary staffing portal Jobandtalent has added $108m to its latest round from investors including Seek to take its total funding to roughly $290m.
Abbisko absorbs $123m in series D round
Lilly Asia Ventures, a regional corporate venturing subsidiary of pharmaceutical firm Eli Lilly, reinvested in a round set to accelerate development of Abbisko’s cancer-focused drug candidates.
Starburst dazzles Salesforce in $100m series C
Salesforce Ventures has backed enterprise data query software developer Starburst in a move aimed at strengthening its Tableau data visualisation tool.
Hologic to buy Biotheranostics for $230m
BioMérieux’s molecular cancer diagnosis spinoff has agreed to a $230m purchase by women’s health-focused Hologic.
Terns earns $87m in series C round
Eli Lilly invested directly and through its Lilly Asia Ventures fund, in a round that brought liver disease-focused drug developer Terns’ overall funding to $197m.
Amazon Music adds Wondery to its playlist
Amazon has agreed to acquire Walt Disney and Bertelsmann-backed podcast creator and publisher Wondery for about $300m.
Metcela settles series B round
The heart disease therapy developer completed a $12.7m round that included Alfresa, Dai-ichi Life, Sony Innovation Fund and Japan Lifeline.
QIA energises Fluence with $125m investment
AES and Siemens’ joint energy storage venture is valued at a little over $1bn in the Qatar Investment Authority-funded transaction.
Flexiv assembles $100m series B
Meituan Dianping and New Hope Group have both thrown their backing behind a round topping $100m for production automation robot developer Flexiv.
Uniontech bonds with series A investors
The Archermind-backed operating system developer was reportedly valued at $734m valuation in a $168m round led by Beijing E-Town.
Meishubao crafts $210m series D round
Bojia Capital reinvested in the Tencent-backed online arts education provider in a round that pushed its overall funding to $305m.
Transcenta triggers $105m crossover round
Lilly Asia Ventures has put more funding into Transcenta to help sustain the antibody drug developer’s clinical-stage pipeline.